Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones

Michael S. Ominsky, Chaoyang Li, Xiaodong Li, +16

Journal of Bone and Mineral Research

A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair

Mónica Florio, Kannan Gunasekaran, Marina Stolina, +26

Nature Communications

Ethnic distribution of the glutathione transferase Mu 1-1 (<i>GSTM1</i>) null genotype in 1473 individuals and application to bladder cancer susceptibifity

Henry J. Lin, Chun-Ya Han, David A. Bernstein, +3

Carcinogenesis

Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene

Henry J. Lin, Chun-Ya Han, Bruce K. Lin, +1

Pharmacogenetics

GeneticsGenetic EpidemiologyAcetylation PolymorphismMolecular BiologyPathology +18

Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury

Xiaodong Li, Mario Grisanti, Wei Fan, +37

Journal of Bone and Mineral Research

Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus

Christine Hamann, Martina Rauner, Yvonne Höhna, +9

Journal of Bone and Mineral Research

Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats

Marina Stolina, Denise Dwyer, Qing‐Tian Niu, +9

Bone

Bone Turnover MarkersSclerostinSclerostin Antibody AdministrationTemporal ChangesImmunology +8

Novel Genetic Models of Osteoporosis by Overexpression of Human RANKL in Transgenic Mice

Vagelis Rinotas, Alexandra Niti, Romain Dacquin, +7

Journal of Bone and Mineral Research

Transgenic Mouse ModelsGeneticsNovel Genetic ModelsTransgenic MiceOrthopaedic Surgery +18

Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody

Xiaodong Li, Qing‐Tian Niu, Kelly Warmington, +10

Endocrinology

Bone DiseaseSclerostin AntibodySclerostinSclerodermaGynecology +11

FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists

Xiaodong Li, Shanaka Stanislaus, Frank Asuncion, +15

Journal of Bone and Mineral Research